Dizziness Kaempferia parviflora,
Conditions
Interventions
Chronic vertigo patient should take the Kaempferia parviflora extraction 1 capsule twice a day for 60 days
Experimental Drug
Kaempferia parviflora extraction capsule
Sponsors
Agricultural Research Development Agency (Public Organization)
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Chronic dizziness patient with symptom persists more than 3 months 2. age between 18-65 years old 3. Consent to participate in the study and able to follow up until finish 4. Never been treated with Kaempferia parviflora or Betahistine in 72 hours prior recruited in to the study 5. Able to read and write in Thai
Exclusion criteria
Exclusion criteria: 1. Patient with diagnosis of BPPV, Vestibular Migraine, Motion Sickness, Height vertigo, Orthostatic Hypotension, Mental or psychiatric problem, Brain or Vestibular nerve tumor 2. Abnormal proprioception test, tremor, hemiplegia paraplegia 3. Patient with asymmetrical SNHL or poor SDS or suspected Acoustic Neuroma 4 Patient with cardiac arrythmia or arrythmia symptoms 5. Patient with active middle ear disease or TM perforate 6. patient who received neuro compressive drugs, aspirin, diuretics,aminoglycosides, anti-cancer,anti-epilepsy, antidepressants 7. Patient with banormal LFT, GFR less than 60 8. Patient who cannot sit and stand 9. Patient who unable to follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improvement of vertigo symptoms at D60 Score of Dizziness Handicap Inventory – Thai version | — |
Secondary
| Measure | Time frame |
|---|---|
| Improvement of Vestibular function D30 and D60 Videonystagmography, Caloric test and Posturography | — |
Countries
Thailand
Contacts
Public ContactKwanchanok Yimtae
Faculty of Medicine, Khon Kaen University
Outcome results
None listed